Article

Proteomic blood profiling in mild, severe and critical COVID-19 patients

2020-06-23

Abstract excerpt

The recent SARS-CoV-2 pandemic manifests itself as a mild respiratory tract infection in the majority of individuals leading to COVID-19 disease. However, in some infected individuals, this can progress to severe pneumonia and acute respiratory distress syndrome (ARDS), leading to multi-organ failure and death. The purpose of this study is to explore the proteomic differences between mild, severe and critical COVI...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c2527e78-b1a0-57d9-b311-f061c5b9642c
DOI: 10.1101/2020.06.22.20137216

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Proteomic blood profiling in mild, severe and critical COVID-19 patientsDOI 10.1101/2020.06.22.20137216Read

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypesSemantic proximity Read

COVID-19 severity is associated with immunopathology and multi-organ damageSemantic proximity Read

Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patientsSemantic proximity Read

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes.Semantic proximity Read

Identification of Robust Protein Associations With COVID-19 Disease Based on Five Clinical StudiesSemantic proximity Read

Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients.Semantic proximity Read

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Semantic proximity Read

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptomsSemantic proximity Read

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19Semantic proximity Read

Blood transcriptome responses in patients correlate with severity of COVID-19 diseaseSemantic proximity Read

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Semantic proximity Read

Large scale phenotyping of long COVID inflammation reveals mechanistic subtypes of diseaseSemantic proximity Read